已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis

医学 美容 耐受性 伊米奎莫德 相对风险 基底细胞癌 置信区间 不利影响 随机对照试验 皮肤病科 光化性角化病 外科 内科学 基底细胞
作者
N.J. Collier,Ann K. Haylett,Terence H Wong,C.A. Morton,Sally H. Ibbotson,Kevin E. McKenna,R. Mallipeddi,Harry Moseley,D.C. Seukeran,Kate A. Ward,M.F. Mohd Mustapa,L.S. Exton,Adèle C. Green,Lesley E. Rhodes
出处
期刊:British Journal of Dermatology [Oxford University Press]
卷期号:179 (6): 1277-1296 被引量:41
标识
DOI:10.1111/bjd.16838
摘要

Topical photodynamic therapy (PDT) is an established treatment option for low-risk basal cell carcinoma (BCC).To compare efficacy, cosmesis and tolerability of PDT for BCC with alternative treatments.MEDLINE, PubMed, Embase and CENTRAL databases were searched from inception until 1 September 2017. Included studies were randomized controlled trials (RCTs) of PDT for nodular (n) and superficial (s) BCC reporting at least one of the following outcomes: clearance at 3 months and sustained at 1 or 5 years; recurrence at ≥ 1 year; cosmesis; adverse events; tolerability.From 2331 search results, 15 RCTs (2327 patients; 3509 BCCs) were included. PDT efficacy (5-year sustained clearance) was high but inferior to excisional surgery [nBCC pooled risk ratio (RR) 0·76; 95% confidence interval (CI) 0·63-0·91], and without re-treatment of partially responding lesions, was modestly inferior to imiquimod (sBCC: RR 0·81; 95% CI 0·70-0·95) and similar to fluorouracil (sBCC: RR 0·88; 95% CI 0·75-1·04). Five-year sustained clearance was inferior with conventional vs. fractionated PDT (sBCC: RR 0·76; 95% CI 0·68-0·84). PDT cosmesis was superior to surgery (sBCC: RR 1·68, 95% CI 1·32-2·14; nBCC: RR 1·82, 95% CI 1·19-2·80) and cryosurgery (BCC: RR 3·73, 95% CI 1·96-7·07), and without re-treatment of partially responding lesions was similar to imiquimod (sBCC: RR 1·01, 95% CI 0·85-1·19) and fluorouracil (sBCC: RR 1·04, 95% CI 0·88-1·24). Peak pain was higher but of shorter duration with PDT than topical treatments. Serious adverse reactions were rarer with PDT than imiquimod (sBCC: RR 0·05, 95% CI 0·00-0·84) and fluorouracil (sBCC: RR 0·11, 95% CI 0·01-2·04). Combination PDT regimens demonstrated reduced recurrence and improved cosmesis; however, results from these small studies were often nonsignificant.PDT is an effective treatment for low-risk BCC, with excellent cosmesis and safety. Imiquimod has higher efficacy than single-cycle PDT but more adverse effects. Highest efficacy is with excisional surgery. Fractionated and combination PDT options warrant further study.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wyj发布了新的文献求助10
1秒前
阿桔完成签到 ,获得积分10
1秒前
2秒前
杨什么龙完成签到,获得积分10
3秒前
yong202发布了新的文献求助10
7秒前
8秒前
小白完成签到 ,获得积分10
9秒前
小珂完成签到,获得积分10
10秒前
10秒前
hahaha发布了新的文献求助10
11秒前
明仕春完成签到 ,获得积分10
12秒前
冰安完成签到 ,获得积分10
14秒前
15秒前
搜集达人应助爱sun采纳,获得10
17秒前
Anby完成签到,获得积分10
18秒前
shan完成签到,获得积分10
19秒前
Hello应助优美翠柏采纳,获得10
21秒前
无幻完成签到 ,获得积分10
23秒前
昏睡的盼秋完成签到,获得积分10
25秒前
季风气候完成签到 ,获得积分10
25秒前
岁岁完成签到,获得积分10
26秒前
waerdenghu完成签到,获得积分20
26秒前
MTF完成签到,获得积分10
28秒前
小丸子完成签到,获得积分10
29秒前
30秒前
长矛沾屎戳谁谁死完成签到,获得积分10
34秒前
34秒前
英勇水杯完成签到,获得积分10
35秒前
李小光发布了新的文献求助10
37秒前
zylv完成签到 ,获得积分10
39秒前
wanci应助小心爱吃肉采纳,获得10
40秒前
小半完成签到 ,获得积分10
42秒前
小唐完成签到,获得积分10
42秒前
李李完成签到 ,获得积分10
45秒前
48秒前
周建齐发布了新的文献求助10
51秒前
doctor2023完成签到,获得积分10
52秒前
whishark发布了新的文献求助10
54秒前
dfgv完成签到,获得积分10
54秒前
yoyo完成签到 ,获得积分10
56秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Applied Min-Max Approach to Missile Guidance and Control 5000
Metallurgy at high pressures and high temperatures 2000
Inorganic Chemistry Eighth Edition 1200
Anionic polymerization of acenaphthylene: identification of impurity species formed as by-products 1000
The Psychological Quest for Meaning 800
Signals, Systems, and Signal Processing 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6325685
求助须知:如何正确求助?哪些是违规求助? 8141840
关于积分的说明 17070989
捐赠科研通 5378173
什么是DOI,文献DOI怎么找? 2854109
邀请新用户注册赠送积分活动 1831741
关于科研通互助平台的介绍 1682804